Healthark Global Capability Centers (GCC)’s Post

Day 2 at #DIA2024! Interesting discussions on #AI in pharma use cases by folks from Clario & Fortrea. Amazing to see Clario running 30 AI models across 800 clinical trials in production. #clinicalresearch #clinicaltrials #artificialintelligence

India’s healthcare #AI market is set to reach $1.6 billion by 2025, transforming the #pharma and life sciences industries. From accelerating #drug discovery and development to improving #clinicaltrial efficiency, AI is redefining the future of healthcare. Discover more in our white paper: https://lnkd.in/eku_cWPX #HealthcareAI #Innovation #IndiaTech #FutureOfHealthcare

Inspired by the generative AI in healthcare panel discussion organised by #SDAIA today! The potential for personalized medicine, drug discovery, and even synthetic data generation is mind-blowing. So many exciting possibilities! #GenAI #Healthcare #AI #MedTech #PersonalizedMedicine #DrugDiscovery

While #AI has made impressive strides in accelerating #drug discovery, we’re just beginning to scratch the surface of its potential. The true game-changer lies in applying AI to the drug development process, particularly in clinical trials. This stage is notoriously lengthy, costly, and complex—yet it’s the most critical in bringing new treatments to patients. Discover how we can transform clinical trials through AI in my latest paper, published on Law360 and created in partnership with Keystone AI. Learn how we can drive #innovation and efficiency in this crucial phase of drug development. In this paper we discuss technological advancements such as digital twins that are enabling this innovation and examine the regulatory challenges and opportunities that could influence adoption in the healthcare industry. Click here to read more: https://bit.ly/4fvKPd3 Really enjoyed working with the Keystone AI team and leaders Mary Scarpulla, Monika Pichler and Aseem Mahajan on this publication. https://lnkd.in/ebgKXwvg

Rediscover valuable insights into the intricate world of drug discovery through Lifebit's blog. Accompany us as we investigate the journey from identifying targets to the realm of Drug Discovery 2.0, where AI and ML technologies supercharge efficiency and efficacy. Our blog post provides a comprehensive overview of the drug development process, shedding light on the stringent standards and extensive clinical trials required to bring new drugs to market. As we adapt to the transition to Drug Discovery 2.0, powered by AI and ML, uncover how innovative technologies are reshaping drug development and offering practical solutions to longstanding challenges: https://hubs.li/Q02CcFG40 #DrugDiscovery #AIinHealthcare #Lifebit

The "Decoding AI in Healthcare" series by MedSynapse explores the transformative role of artificial intelligence in various medical fields. Episode 30 focuses on AI's impact within the biopharmaceutical industry. In this episode, David A. Hall, Managing Director at AKT Health, and Dr. Dipu Patel, a Digital Health Consultant and AI Entrepreneur, discuss: Current Trends: The evolving landscape of AI in biopharma. Applications: AI's role in drug discovery, clinical trials, and patient care. Challenges: Obstacles in implementing AI technologies. Future Outlook: The potential trajectory of AI in enhancing biopharma processes and patient outcomes. https://lnkd.in/dNr5hSfH

The "Decoding AI in Healthcare" series by MedSynapse explores the transformative role of artificial intelligence in various medical fields. Episode 30 focuses on AI's impact within the biopharmaceutical industry. In this episode, David A. Hall, Managing Director at AKT Health, and Dr. Dipu Patel, a Digital Health Consultant and AI Entrepreneur, discuss: Current Trends: The evolving landscape of AI in biopharma. Applications: AI's role in drug discovery, clinical trials, and patient care. Challenges: Obstacles in implementing AI technologies. Future Outlook: The potential trajectory of AI in enhancing biopharma processes and patient outcomes. https://lnkd.in/dNr5hSfH

Transforming Drug Development with AI Traditional drug development faces high failure rates, massive costs, and lengthy timelines. AI-driven precision medicine is revolutionizing this process by enhancing efficiency, accuracy, and speed. Discover how AI and machine learning are paving the way for personalized treatments and better patient outcomes. 🚀 #DrugDevelopment #PrecisionMedicine #AIinHealthcare

The "Decoding AI in Healthcare" series by MedSynapse explores the transformative role of artificial intelligence in various medical fields. Episode 30 focuses on AI's impact within the biopharmaceutical industry. In this episode, David A. Hall, Managing Director at AKT Health, and Dr. Dipu Patel, a Digital Health Consultant and AI Entrepreneur, discuss: Current Trends: The evolving landscape of AI in biopharma. Applications: AI's role in drug discovery, clinical trials, and patient care. Challenges: Obstacles in implementing AI technologies. Future Outlook: The potential trajectory of AI in enhancing biopharma processes and patient outcomes. https://lnkd.in/dNr5hSfH

The "Decoding AI in Healthcare" series by MedSynapse explores the transformative role of artificial intelligence in various medical fields. Episode 30 focuses on AI's impact within the biopharmaceutical industry. In this episode, David A. Hall, Managing Director at AKT Health, and Dr. Dipu Patel, a Digital Health Consultant and AI Entrepreneur, discuss: Current Trends: The evolving landscape of AI in biopharma. Applications: AI's role in drug discovery, clinical trials, and patient care. Challenges: Obstacles in implementing AI technologies. Future Outlook: The potential trajectory of AI in enhancing biopharma processes and patient outcomes. https://lnkd.in/dNr5hSfH